Funding · Company

Epicrispr Biotechnologies, Inc.

South San Francisco, CABiotech & Pharma

Epicrispr Biotechnologies, Inc. of South San Francisco, CA has disclosed $177M across 1 Form D offering filed with the SEC on Aug 26, 2026.

$177M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$177M

Form D · Aug 26, 2026 ↗

Q3 2026 · target $213M

Filing details

HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0002151604Offerings on file1

Links

All SEC filings for this company ↗ epicrispr.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →